Grifols (GIKLY) Enterprise Value Growth (3y) (2013 - 2025)

Grifols (GIKLY) Enterprise Value Growth (3y) (2013 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -16.86%
Dec 31, 2024 29.74%
Dec 31, 2023 -35.42%
Dec 31, 2022 -36.46%
Dec 31, 2021 -65.92%
Dec 31, 2020 46.92%
Mar 31, 2020 143.59%
Dec 31, 2019 46.76%
Sep 30, 2019 32.71%
Mar 31, 2019 32.10%
Dec 31, 2018 18.93%
Sep 30, 2018 9.96%
Jun 30, 2018 4.15%
Mar 31, 2018 37.74%
Dec 31, 2017 7.87%
Dec 31, 2016 -0.13%
Sep 30, 2016 -15.69%
Jun 30, 2016 -13.89%
Mar 31, 2016 -27.70%
Dec 31, 2015 -27.00%